Based on the clinical evidence and the patient profiles where the compound appears most applicable, the following characteristics tend to describe good candidates for AOD 9604 evaluation when it is medically supervised: Patients with stubborn localized fat deposits that have not responded to diet and exercise, particularly visceral and lower abdominal fat Patients who cannot tolerate GLP-1 medications due to nausea, gastrointestinal side effects, or contraindications Active patients with reasonable baseline metabolic health who want a targeted lipolytic tool to complement their training and nutrition program Patients already on a peptide protocol who want to add a fat-targeting element to a GHK-Cu, NAD+, or sermorelin stack Patients who are not candidates for stimulant-based fat loss medications due to cardiovascular sensitivity, anxiety, or blood pressure concerns AOD 9604 is not appropriate as a standalone weight loss strategy for patients with significant obesity, insulin resistance, or metabolic syndrome

Skin Repair and Extracellular Matrix Research Copper serves as an essential cofactor for numerous enzymes involved in collagen synthesis, antioxidant defense, and connective tissue maintenance
Keep reading to discover everything you need about B12 and weight loss
AOD-9604 5mg Research-grade AOD-9604, a synthetic 16-amino-acid peptide fragment (Tyr-hGH 176-191) derived from the C-terminal domain of human growth hormone